Income statement
EUR
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 60M | 51M | 34M | 44M | 45M |
| Gross Profit | 47M | 34M | 17M | 32M | 53M |
| Operating Income | -15M | -4M | -29M | -583K | 11M |
| EBITDA | 12M | 3M | -24M | 1M | 15M |
| Net Income | -13M | -4M | -23M | -2M | 9M |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$15.13
+0.00% today
1Y Change
-25.38%
Window
Jun 23, 2025 → Jun 11, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Remedy Entertainment Oyj (RMDEF) is a Technology stock with a market cap of $170.00M and listed on OTC. The stock last traded around $15.13 and down 25.4% across the available one-year price window (Jun 23, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of +17.5%, EPS growth of -251.9%, a dividend yield of 0.0%. What stands out right now is revenue +17.5%, EPS -251.9%, free cash flow -87.9% with operating margin -0.4% and ROIC -0.3%. Valuation is more restrained than many high-expectation growth names at price/sales 3.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RMDEF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RMDEF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RMDEF Max Drawdown
-25.38%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RMDEF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$44.7M
+2.6% YoY
FY Net Income
$8.8M
+609.5% YoY
Free Cash Flow
-$7.4M
-1900.9% YoY
Revenue Growth
+17.5%
EPS Growth
-251.9%
Gross Margin
79.8%
Net Margin
-1.4%
Income statement
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 60M | 51M | 34M | 44M | 45M |
| Gross Profit | 47M | 34M | 17M | 32M | 53M |
| Operating Income | -15M | -4M | -29M | -583K | 11M |
| EBITDA | 12M | 3M | -24M | 1M | 15M |
| Net Income | -13M | -4M | -23M | -2M | 9M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 10M | 21M | 20M | 49M | 51M |
| Total Assets | 88M | 99M | 79M | 100M | 100M |
| Total Liabilities | 31M | 31M | 12M | 11M | 13M |
| Shareholder Equity | 57M | 69M | 68M | 88M | 87M |
| Total Debt | 18M | 16M | 4M | 3M | 4M |
| Net Debt | 9M | -5M | -16M | -46M | -49M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
5M
-53.2% YoY
Capital Expenditures
13M
-18.2% YoY
Free Cash Flow
7M
-1900.9% YoY
Key ratios
Gross Margin
79.8%
Operating Margin
-0.4%
Net Margin
-1.4%
ROE
-1.2%
Debt / Equity
0.32x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.